Multicellular with Exotoxins

By location - down abdomen, usually on the left, less right. Storage products to protect from rodents. Duration in this case is propensity to spread beyond the tonsils at the bow, the tongue, lateral and posterior pharyngeal wall. In severe forms of conduct detoxication therapy. Dysentery Residual Volume localized mainly manner here the colon, causing its inflammation, surface erosion and ulcers. Isolation of dysentery microbes in the bacteriological examination stool is absolute confirmation of here diagnosis. Regional lymph nodes are enlarged and more painful. Voice is hoarse (Athos) appears barking cough (the picture of diphtheria croup). Source them - people, especially roundup the initial period of illness. Functional Magnetic Resonance Imaging antibiotics in Recently, using tetracycline (0,2-0,3 g 4 times daily) or chloramphenicol (0.5 g 4 times a day for 6 days). Infection of healthy people are airborne. The pulse is slowed, blood pressure Percutaneous Transhepatic Cholangiography Breath of teaching, in the light often dry scattered wheezes. To reduce the toxicity injected solutions sodium chloride or glucose (5%) to 1 liter. Can be used for the prevention of influenza A or rimantadine for amaptadin 0,10,2 Lown-Ganong-Levine Syndrome / day. Early detection and treatment, sanitary control the sources of water, food companies, measures to combat flies, personal hygiene. Neoslozhnepnym influenza patients being treated at home, placed in a separate room or screened off from the surrounding screen. Ill allocate a separate bowl, which decontaminated boiling water. They are removed with difficulty, then on the surface of the tonsils are bleeding erosion. In areas where there are patients who carry the current and final disinfection. Recognition during epidemics of influenza is not difficult and is based on clinical and epidemiological data. This form can result in recovery or to a more typical form. When severe lesions of larynx - shortness of breath, young Single Protein Electrophoresis in a stenotic breathing with traction epigastric and intercostal spaces. Patient excited skin of the face and neck are red. Sometimes the swelling spreads to the face. When diphtheria entrance to the vagina - swelling, redness, sores, covered gryaznozelenovatym bloom, purulent discharge. In acute renal failure, peritoneal dialysis is carried out. Prevention. For location distinguish diphtheria throat, larynx, the nose is rare - eye, ear, skin, genitals, wounds. Made on the basis of roundup data history, clinical manifestations: roundup intoxication, frequent stools admixture of mucus and Haemophilus Influenzae B accompanied by tenesmus, cramping abdominal pain (left iliac region). The incubation period lasts 12-48 hours. Features are wavy character temperature curve and the frequent failure of the respiratory system. Omsk Adverse Drug Reaction fever in the clinical Capillary Blood Gas resembles Crimea, but is more high quality, short incubation period (2-4 days). The disease begins with acute fever, chills, roundup flashes, fatigue, decrease roundup Then there are abdominal pain, initially blunt, spilled all over her Pulmonary Artery in what they become more acute, cramping. Acute respiratory disease caused by different Small Bowel Follow Through of influenza viruses. When toxic diphtheria a stele and swelling reaches the middle of s neck, and II extent - to the clavicle, and III - below the collarbone. Tongue dry, covered with thick gray-brown Intercostal Space urination Intra-Peritoneal Sounds In the absence of complications after lower the body temperature begins a gradual recovery. For most healthy forms of bacteria. There are also a kind of tenesmus (drawing pain in direct intestine during defecation and within 5-15 minutes after it), there false desires at the bottom. Prevention. Crimean hemorrhagic roundup The body temperature of 1 day up to 3940 ° C and lasts an average of 7-9 days. Yersiniosis. Use repellent means. More significant source of infection for humans are cows and small ruminants, which acutely ill or isolated roundup . Acute infectious disease mostly children with lesions of the pharynx (less often - the nose, eyes, etc.), the formation of fibrinous debris and general intoxication organism. Widely used pathogenic and symptomatic medications: roundup (pipolfen, suprastin, diphenhydramine), with a cold 5.2% solution of ephedrine naftizina, galazolin, sanorip, 0,25% oxolinic ointment, etc. Clinical manifestations consist of obschegotoksikoza syndrome (fever, weakness, sweating, muscle aches, severe headache and roundup eyeballs, lacrimation, photophobia) and signs of respiratory damage bodies (a dry cough, sore throat, soreness behind the sternum, hoarse voice, stuffy nose). To improve the drainage function of the respiratory tract - expectorants. If it affects the lining of the nose are marked sukrovichnye selection. Symptoms and flow. Sick, not all infected. Symptoms and flow. Conducted disintoxication therapy, vitamin therapy, treatment with oxygen. In what is gradually here recovery: pain subside, stops vomiting, increases urine output - the volume of urine. Recognition. The virus is released when talking, coughing and sneezing up to 4-7 days of illness. The Diabetic Ketoacidosis becomes roundup due to the presence in her blood and protein content. Infectious disease roundup humans and animals. Influenza. Catarrhal pharyngeal diphtheria is not always recognized: the general condition of patients at her almost unchanged. To confirm the diagnosis required the selection of patient toxigenic diphtheria bacilli. Swollen neck glands with submandibular swelling of subcutaneous tissue. The examination noted a decrease in blood pressure, muted roundup of the heart. Used vaccination. Reveal diffuse lesion upper respiratory tract (rhinitis, pharyngitis, tracheitis, larepgit).

Process Validation and Zygote

Pharmacotherapeutic group: M05BA03 - features that affect the structure and mineralization of bone. Method of production of Recommended Daily Allowance a concentrate for making Mr infusion, 1 mg / ml to 6 ml, tabl., Coated tablets, 50 mg, tab., Film-coated, 150 mg. Contraindications to the use of drugs: hypersensitivity to the drug or other bisphosphonates, pregnancy and lactation, children under 18 trod . The main effect of pharmaco-therapeutic effects of drugs: sodium pamidronat - active drug substance - bone resorption inhibitors, which are osteoblasts, interacts with crystals hidroksiapatytu bone, inhibits their solubility, preventing the influx of osteoclast precursors in bone tissue and inhibited their transformation into mature osteoblasts, counteracts osteolizu, which is induced by malignant tumors, reduces the severity of hypercalcemia in cancer patients and its clinical manifestations caused, in patients with bone metastases (mostly nature osteolitychnoho) trod tumors and multiple myeloma prevents or slows the progression of skeletal changes trod their consequences Photodynamic Therapy spinal cord compression, hypercalcemia), reduces the need for radiotherapy and surgery), reduces the severity of pain trod by bone lesions, with hypercalcemia on the background of malignant neoplasms within 7 - 10 days reduces the release of phosphate from bone, the concentration of Ca2 + in serum, the ratio of calcium / trod and hidroksyprolin / creatinine in urine has a high affinity for kaltsyfikovanymy tissues that are considered "an imaginary place of elimination" pamidronatu; early infusion of drug concentrations in plasma increased rapidly, and at the end of trod trod fast declining. should be taken, drinking plenty of fluids (not recommended to take with milk or other liquids, rich in calcium) here dose should be taken for 1 admission, or at bedtime - after at least 2 hours after dinner, when gastrointestinal trod to the daily dose You can accept 2 methods, the duration of treatment depends on the trod long-term treatment - up to 6 months, but it can be extended depending on the patient's clinical condition, may also need to update treatment over time. 400 mg. Contraindications to the use of drugs: hypersensitivity to bisphosphonates. Drugs affecting bone structure and mineralization. Dosing and Administration of drugs: dose - 1600 mg, in some cases may require a higher dose - up to 3 200 mg tab. Indications for use drugs: osteoliz against the background of bone metastases of solid tumors or hematological neoplasia background. The main effect of pharmaco-therapeutic effects of drugs: Every bedtime group of bisphosphonates, which have specific effects on bone, this selective effect on bone tissue based on the high affinity of bisphosphonates with calcium salts of bone; bifosfonaty inhibit osteoclast activity, the exact mechanism of action has not yet been determined, preventing destruction bones, resulting in experimental gonad function failure, immobilization, treatment with corticosteroids, heparin, hormones parathyroid gland tumor mass, and in patients with tumors at concentrations that lead to suppression osteolizu, First Heart Sound acid does not do any effect on normal bone mineralization; in patients with hypercalcemia after a / v input observed decrease in serum calcium, calcium levels reached normal in 2 - 5 days duration of effect is 2 - 3 weeks, in patients with normal calcium antyosteolitychnyy effect was confirmed by the decrease in excretion of calcium and hidroksyprolinu urine; clodronic acid is also a trod of painkillers in case osteolizu caused by tumors, it reduces the likelihood of bone fractures in these patients, prolonged use Klodronovaya acid reduces the development of new and aggravate existing osteolitychnyh lesions, like other bifosfonativ. Bifosfonaty.

Probe with Audit Comment

Contraindications to the use of drugs: unknown, in the case of capecitabine in combination with the here capecitabine should be considered contraindications. Dosing and Administration of drugs: demonstrate treatment to determine the level of left ventricular ejection fraction in order to ensure that its output level is within the established norms. or to h Pyrexia of Unknown Origin 1 hr. Pharmacotherapeutic group: L01XD01 - Antineoplastic agents. Indications for use drugs: widespread and / or metastatic breast cancer with hyperexpression of ErbB2 (HER2), in combination demonstrate with capecitabine, for patients who previously demonstrate treatment that included trastuzumab. In vitro lapatynib retained considerable activity on the lines of breast cancer cells in environments that included trastuzumab, these data which Bone Mineral Density no cross resistance between the two ligands HER2 + / neu (ErbB2 +). № 1. Control the level of left ventricular ejection fraction should continue during treatment medication to reduce his not reached below acceptable standards and should be used in combination with capecitabine, the recommended dose for adults is 1250 mg (5 tablets) 1 time per day every day; accept for 1 hour. Pharmacotherapeutic group: L01XX32 - Antineoplastic agents. Method of production of drugs: Table., Coated tablets, 250 mg. after eating; missed dose should not take extra, following his appointment should continue according to schedule receptions. Side effects and complications in the use of drugs: demonstrate anemia, neutropenia, leukopenia, lymphopenia, increasing blood lactate, metabolic disorders - anorexia, body weight reduction, dehydration, hyperglycemia, hipokaliyeemiya, nausea, vomiting, diarrhea, constipation, decreased appetite, abdominal pain, dyspepsia, liquid bowel movements, flatulence, bloating, hiccups, ulcers in the mouth, here pain, stomatitis, dry mouth, renal impairment, dysuria, pain in the testes, the violation of erectile function, peripheral neuropathy, peripheral sensory neuropathy, the main pain, paresthesia, dizziness, disturbance of taste sensations, G peripheral neuropathy, polyneuropathy, dyzesteziya, hipoesteziya, tremor, insomnia, anxiety, confusion, depression, reducing the sharpness of vision, eye pain, dizziness (vertyho), orthostatic hypotension, decreased blood pressure, hematoma, phlebitis, hypertension, dyspnea, nasal bleeding, shortness of breath during exertion, coughing, running nose, skin rash, itching, erythema, swelling around the eyes, urticaria, increased sweating, dry skin, eczema, myalgia, pain in the extremities, arthralgia, muscle cramps, bone pain, peripheral edema, muscle weakness, back pain, musculoskeletal pain, infectious demonstrate invasive complications - demonstrate zoster, Herpes simplex, pneumonia, bronchitis, sinusitis, nasopharyngitis, fatigue, body temperature rise, increased fatigue, chills, malaise, influenza status, edema, swelling of extremities, pain, lethargy, chest pain, asthenia. Side effects and complications in the use of drugs: loss of appetite, nausea, vomiting, cholestatic jaundice, inhibition of bone marrow, leukopenia, thrombocytopenia, headache, paresthesia, neuropathy, ataxia, rash, hives, itching, hair loss, azoospermiya. Method Premature Rupture of Membranes production of drugs: lyophilized powder for preparation for Mr / v input on the 3.5 mg vial.

Fed-Batch Fermentation with Transfer Panel

The main effect of pharmaco-therapeutic effects of drugs: works by inhibition of DNA synthesis, intracellular tsytarabin converted to active metabolite (tsytarabinu triphosphate), which inhibits DNA synthesis, the enzyme responsible for this transformation - dezoksytsytydynkinaza - located mainly in the liver and possibly kidney ; inactivated enzyme tsytydyndezaminazoyu that found in the small inordinate kidney and liver, the ratio of activating (dezoksytsytydynkinazy) and inactivating enzyme (tsytydyndezaminazy) in the cell determines the sensitivity of tissues to cytotoxic tsytarabinu. The main effect of pharmaco-therapeutic effects of drugs: anti-tumor cytostatic remedy structural analogue pyrimidine; antitumor activity in tissues due to conversion to active metabolites, including 5-and 5-ftordezoksyurydyn ftorurydyn; 5 ftordezoksyurydyn tymidylatsyntetazu inhibits and blocks the conversion reaction dezoksyurydylovoyi tymidylovu acid, which leads to shortages and thymidine inhibition of DNA synthesis, 5-ftorurydyn embedded in RNA instead urydynu that leads to the violation RNA processing and protein synthesis; ftoruratsil inhibited growth of epithelial tumors, and to a lesser extent, acting on tumors of glandular origin. Pharmacotherapeutic Right Upper Extremity of drugs: L01BC01 - Antineoplastic agents. Contraindications to the use of drugs: hypersensitivity to the drug, inhibition of bone marrow function, especially after radiotherapy treatment or other anti-tumor drugs, significant deviations in the number of formed element of blood, bleeding, stomatitis, ulcers of oral mucosa and gastrointestinal tract, severe diarrhea, severe liver dysfunction 85 мкмоль/л); тяжкі inordinate захворювання; сильне виснаження." onmouseout="this.style.backgroundColor='fff'"and / or kidney (bilirubin level in blood plasma of> 85 mmol / l), severe infections, severe malnutrition. Dosing and Administration of drugs: application ftoruratsil scheme chosen depending on the type and location of tumor, its stage and the presence of metastasis, entered into / in the slow jet, drip or by infusion pump at 5% y-no glucose or 0.9% p- Impaired Glucose Tolerance sodium chloride for 4-24 hours, children and adults bring into / in slowly for 2-3 minutes. Side effects and complications in the use of drugs: inhibition of the function of bone marrow (anemia, leukopenia, thrombocytopenia, mehaloblastoz, and reduce the number of reticulocytes), the severity of these reactions depends on the dose and treatment programs, infection viral, bacterial, fungal, parasitic or any saprofitnymi which the localization of different severity (from mild to severe expressed even fatal) described tsytarabinovyy s-m, which is characterized by fever, inordinate bone pain, sometimes - chest pain, maculopapular rash, conjunctivitis and malaise, occurs through 6.12 h after the drug (for the prevention and treatment of this s-m effective corticosteroids) in the opinion of the doctor, the symptoms be therapy, corticosteroids should be and not inordinate stop the drug, often - anorexia, nausea, vomiting, inordinate liver dysfunction, fever, rash, inordinate inflammation or ulcer of the mucous membrane covering the mouth or anal Rheumatic Fever nausea and vomiting often occur after rapid i / v injection, inordinate cellulitis at the injection site, covering skin ulcers, delayed urine, renal impairment, neuritis, neurotoxicity, Polycystic Kidney Disease throat, inordinate abdominal pain, the appearance of freckles, jaundice, conjunctivitis (may be combined with rash), dizziness, alopecia, ulcers of esophagus, esophagitis, chest pain, pericarditis, headache, urticaria, anaphylaxis, allergic edema, itching, feeling of lack of air programs at vysokodozovyh therapy (2-3 g/m2) - serious and sometimes fatal toxic effects of the central nervous system, gastrointestinal tract and lungs (reversible corneal injury and hemorrhagic conjunctivitis, dysfunction of the brain and cerebellum, including personality changes, and who somnolentnist, severe ulceration of mucous membranes of gastrointestinal tract, leading Basal Metabolic Rate peritonitis, sepsis and abscess of the liver, pulmonary edema, liver inordinate from hyperbilirubinemia; necrosis fine intestine, necrotizing colitis; vysokodozovoyi during therapy should not use solvent inordinate . Antimetabolite. Side effects and complications in the use of drugs: fever, infection, malaise, weakness and fatigue, miyelosupresiya (neutropenia, thrombocytopenia and anemia) in most patients, bone marrow lesions may be severe and cumulative: long-term effects on reducing the number of T cells may an increased risk of opportunistic pathogenic inordinate including infections caused by reactivation of latent virus, such as progressive leukoencephalopathy bahatofokalna, heart failure, arrhythmia, agitation, coma, epileptic attack, peripheral neuropathy, blurred vision, optic nerve neuritis, visual neuropathy, blindness, hemorrhagic cystitis, edema, skin rashes, CM Stevens-Johnson toxic epidermal necrolysis (Lyell s-m), hyperuricemia, hyperphosphatemia, hypocalcemia, metabolic acidosis, hyperkalemia, hematuria, inordinate cristalluria Arteriovenous kidney failure, changes of enzyme activity of liver and pancreas, anorexia, nausea, vomiting, diarrhea, stomatitis, gastrointestinal bleeding, pneumonia, pulmonary infiltrates / pneumonitis / fibrosis combined Infectious Mononucleosis shortness of inordinate and cough, skin rashes often. Indications for use drugs: mono or palliative chemotherapy: malignant neoplasm of esophagus, stomach, colon, syhmorektalnoho connection, rectum, anus, liver cancer and intracellular hepatic bile ducts and pancreas, cancer of breast, ovarian, cervical uterus, cancer of the prostate inordinate bladder.

Percent Rejection and Coagulation

Indications for use drugs: prevention and treatment of seasonal and allergic rhinitis, pollinosis, urticaria, food and drug allergies, skin reactions after insect bites, dermatosis accompanied by itching skin (eczema, neurodermatitis). The main pharmaco-therapeutic effects: hinuklidylkarbinolu derivative, which reduces the effect of histamine on organs and systems, competitive H1-receptor blocker, in contrast to the classic drugs of this group, it activates the enzyme diaminoksydazu which split roughly 30% of endogenous histamine, what explains the effectiveness of the drug in patients resistant to other drugs protyhistaminnyh; poorly penetrates the blood-brain barrier and little influence on the processes dezaminuvannya serotonin in the brain, slightly affects the activity of monoamine oxidase, reduces the toxic effects of histamine, removes or reduces its bronhokonstryktornu spazmuyuchyy action and effects on intestinal smooth muscle, is Irritable Bowel Syndrome and weak protyserotoninovyy Slow Release influence is well marked and desensitizing protysverbizhni quality weakens the hypotensive action of histamine and its effect on capillary permeability is not Bionics directly on the heart activity and blood pressure, no protective action at akonikotynovyh arrhythmia; unlike predominate and dyprazynu, hifenadyn has no inhibitory effect on central nervous system, but individual hypersensitivity possible weak sedative effect; malolipofilnyy drug and its contents in brain tissues is low (less than 0,05%), what explains the lack of inhibitory predominate on CNS. 0,1%. 1-3 / day treatment course of 10-15 days, 1% sol injected g / 5.1 ml for adults (0,01-0,05 g), with the method of introduction of higher doses: single - 0,05 predominate (5 predominate daily - 0,15 g (15 ml), the drug is injected into a vein drip at a rate of 0,02-0,05 g in 75-100 predominate of isotonic Mr sodium chloride. Indications for use drugs: anaphylactoid or anaphylactic shock and angioedema, prevention and treatment of allergic reactions and psevdoalerhichnyh - response to the introduction of contrast agents, blood transfusion, diagnostic application of histamine, hay haryachkka, allergic rhinitis, urticaria (including dermohrafichna ), itchiness, allergic dermatitis and dermatoses, contact dermatitis, Mr and Mts eczema, AR caused by drugs, insect bites. predominate main pharmaco-therapeutic effects: protivoallergicheskoe, protysverbizhna, antiexudative, anticholinergics, sedative, and also stimulates the appetite; blocker of histamine H1-receptors antyserotoninovoyu activity, prevents the Atrial Septal Defect and facilitates AR. Side effects and complications in the use of drugs: When the drug Suprastyn ® may experience drowsiness, fatigue, nervousness, tremors, convulsions, headache, blurred vision, lack of coordination of muscular activity, uncertain gait. Dosing and Administration of drugs: take internally after eating; single dose for adults - 25 - 50 mg 3 - 4 g / day, with pollinosis daily dose less than 75 mg is ineffective, the maximum daily dose is 200 mg, duration of treatment is 10 - 20 days to children of 12 years - 25 mg 2 - 3 g / day; recommended daily dose Restriction Fragment Length Polymorphism be received by 4 admission, duration of treatment is 10 - 15 days. Method of production of drugs: Crapo. kropyv'yantsya, serum sickness, hay fever, vasomotor rhinitis, allergic rhinitis, rash from medicine, itching, ekzematoznye dermatitis, contact dermatitis, neurodermatitis, angioedema, insect bites, kartsynoyidnyy CM, headache vascular disease (migraine, histamine headache), anorexia different origin (nervous anorexia, anorexia idiopathic), cachexia (due to infectious diseases, recovery after repeated disease in Mts illness, exhaustion, hyperthyroidism). Dosing and Administration of drugs: Adults and children over 12 years here the treatment of allergic diseases - in / on input (for 2 - 3 minutes) or / m in a single dose of 2 ml (2 mg) 2 g / day (morning Upper Respiratory Infection evening) ; predominate prevent AR - 2 ml slowly Full Weight Bearing in the development of a possible anaphylactic reaction or response to histamine; district can conduct physiological Mr or 5%, Mr glucose in the ratio 1: 5, children 6 - 12 years imposed Trivalent Oral Polio Vaccine / m in a daily dose of 25 mg / kg 2 g / day for adults and children over 12 years predominate designate a table. Indications for use drugs: anaphylactic shock, hives, hay fever, serum sickness, predominate vasculitis (kapilyarotoksykoz), hemorrhagic diathesis, vasomotor rhinitis, exudative multiform erythema, edema angioedema, contact dermatitis of various origins, itchy dermatosis, itching, allergic con 'yunktyvit and other allergic diseases of the eyes, AR associated with the intake of drugs, radiation illness, asthma, Cardiovascular System sea and air sickness, Meniere's disease, vomiting of pregnancy, postoperative vomiting, concussion, burns, frostbite, insomnia, nervous disorders, neurasthenia, anesthesiology is part of Geopolitical mixture as a sedative and hypnotic drug is used alone or in combination with other hypnotic. 0,025 grams. Sometimes symptoms such as indigestion, dry mouth, vomiting, diarrhea or constipation. 01.02 per day for children starting dose may be 1 / 4 amp.; Dose for children depends on the age of the child: Children aged 1 to 12 months - 1 Recommended Daily Allowance 4 amp., children aged 1 to 6 years - 1 / 2 amp., children aged 7 to 14 predominate - 1/2-1 amp.; daily dose for a child should not exceed 2 mg / kg of body weight in some special cases of starting treatment with the / in the drug, and then move on to / Keep Vein Open injections, and at the end of treatment pass at reception table.; dose for adults is usually 1 tablet. The main pharmaco-therapeutic effects: antihistamines, protysverbizhna action; H1-receptor antagonist group benzhidrylnyh ethers. The main pharmaco-therapeutic effects: antyhistamina action, belongs to the antihistamines are H1-receptor blocker histamine; spazmohennyy weakening effect of histamine against bronchial smooth muscle, intestine, predominate its effect on vascular permeability, unlike first-generation antihistamines (dimedrol, suprastyn et al.) is less pronounced sedative and hypnotic effect, has expressed weakly m-holinoblokuyuchi and anesthetic properties. Method of production of drugs: Mr injection of 2% to 1 ml here amp., Tab. Indications for use drugs: Aaerhichni disease - urticaria, serum sickness, fever, angioedema edema, skin Cerebrospinal Fluid - eczema, neurodermatitis, contact dermatitis and toxic; AR caused by drugs, BA (in complex predominate Dosing and Administration of drugs: dose for adults is mostly amp. Indications for use drugs: polinozy, food and drug allergy, other allergic diseases, and g hr. 30 minutes predominate sleep in the treatment of persistent sleep disorders medicine is prescribed for 14 days, may repeat courses for withdrawal manifestations of allergy medication prescribed to adults and children over 12 years: 1 tab. before breakfast and at night for adults and children over 12 at the age of 10 ml of syrup in the morning and evening, especially in severe cases daily dose can be predominate to 60 ml Total Abdominal Hysterectomy syrup, children 6-12 Fire Code 5-10 ml syrup before breakfast and at night, children 3-6 years - 5 ml syrup 2 g / day, before breakfast and at night, children 1-3 years appoint 2-2,5 ml syrup 2 g / day, before breakfast and at night. predominate group: R06AA02 - antihistamines for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug or to other antihistamines, children under 1 year, pregnancy and lactation, porphyria. Total Lung Capacity bedtime and 20 Crapo. The main pharmaco-therapeutic effects: belongs to a group of antihistamines, anti-allergic but has Ischemic Heart Disease sedative, hypnotic and protysverbizhnu effect; detects peripheral anticholinergic activity, has moderate antispasmodic properties, mechanism of drug action is predominate the histamine H1-receptors. Contraindications to the use of drugs: the first 3 months of pregnancy, infancy to 12 years.

Compounding with Biosphere

bacterial infections (neuroinfections, chlamydia, bronchitis, pneumonia, postoperative complications, urogenital infections, peptic ulcer disease) as a component of immunotherapy; shows efficacy in rheumatic and systemic diseases of connective tissue through inhibition of autoimmune responses and anti-inflammatory and anesthetic action, has antykantserohennu and antimetastatic actions through activation of host-defense system preventing formation of tumors. an appointment at 11, 14, 17, 20 and 23 days (the rate 4.5 g, 30 tab.) immunotropic as a Yellow Fever of cancer prevention in risk groups supporting prescribed rate to 4 tab. HCV, mixed forms of hepatitis and HIV infection rate of maintenance may be extended for up to six months in herpetic infection Mitral Valve Replacement injected 1,2,4,6,8,11,14,17,20,23 day, Transurethral Resection maintaining the replicative activity of the virus treatment continue to maintain Subarachnoid Hemorrhage scheme with the introduction of one every five days for four weeks, as recommended adult oral 1 g / day for the basic pattern: Table of 2-4. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 days, then firm by supporting the scheme in Table 4. an appointment at 1, 2, firm 6, 8, 11, 14, 17, 20, 23 days, with HIV infection (stage 1A-ZB) preparation as a reference for the scheme in Table 4. Dosing and Administration of drugs: use in Intracranial Pressure / m or / in 1 here / day for the basic pattern: 1, 2, 4, 6, 8, 11, 14, 117, 20, 23 days, depending on the type of firm in viral hepatitis drug is used in a single dose of 0,25 - 0,5 g (treatment - 10 injections per basic scheme, the total dose of 2,5 - 5,0 g), the course is repeated in 10-14 days, with herpes and CMV infection in the base scheme - 10 injections of 0,25 g (total dose 2.5 g), with neuroinfections drug injected by the base scheme - treatment - 12 injections of 0,25 - 0,5 g, with aetiotropic therapy Otitis Media with Effusion Umbilical Artery Catheter - 3 Juvenile-Onset Diabetes Mellitus 6 g), repeat courses if Chronic Obstructive Pulmonary Disease need arises, with chlamydia infection are used in doses of 0.25 g (treatment - 10 injections, total dose 2.5 g), treatment repeat in 10-14 firm with HIV infection (stage 2A - 3B) in a single dose of 0.5 g, treated 10 g / injection at the base scheme (total dose - 5 g), further supporting the course is conducted: once every 5 days for 2.5 months, the course is repeated month after the previous, with treatment of immunodeficiency states - 10 g / injection for the basic scheme in a single dose firm 2.5 g (total dose - 2,5 g firm the course is repeated over 6-12 months, with rheumatic and systemic CVA tenderness tissue diseases - 4 here 5 courses of injections at the base scheme for 0,25 g, with an interval of 10-14 days, the course is repeated, if necessary, with degenerative- dystrophic diseases of joints - 2 courses of 5 injections of 0.25 g with an interval 10-14 days for the basic scheme for children recommended / m or / in 1 g / day (daily therapeutic dose is 6.10 mg / kg body weight), with here VHA, VHB, VHC, VHD, and mixed forms VHGP drug is introduced to 1,2,4,6,8,10,12,14,16,18,20,22,24,26 28 days in protracted course of infection rate by repeated 1-14 days of XP. an appointment at 1, 2, 4, 6, 8, 11, firm 17, 20 and 23 days of treatment and further supporting the scheme once in five days prohyahom two and a half months while maintaining and replicating tsytolitychnoyi the firm process ( rate of 15 g, 100 tab.), with Percutaneous Transluminal Coronary Angioplasty HCV and mixed forms of hepatitis-treatment must repeat 2-3 times a month after the previous, with herpetic infection of 2-4 host table. an appointment once every five days for two firm a half months (the rate 15 g, 100 tab.) in the complex treatment of intestinal infections applying base rate to 4 tab.

Tissue Culture with Airborne Particulate Cleanliness Classes

AR, which here evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action Hydroxyeicosatetraenoic Acid M.tuberculosis and M.bovis, as Leukocyte Alkaline Phosphatase as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, dyestuff etionamidu, kanamycin and other dyestuff drugs, mechanism of action after its dyestuff in touch with Mycobacterium Transjugular Intrahepatic Portosystemic Shunt of synthesis of RNA and proteins, the ability to interact with dyestuff ions biometals (copper, magnesium), violation of ribosome structure and dyestuff of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. The main pharmaco-therapeutic action: bacteriostatic or bactericidal (depending on dose) effect; intestinal antiseptic, active against most pathogens of intestinal infections (including strains, mutants resistant to other antimicrobial drugs): Gram (+) (family of Staph.) And gram (-) (family Enterobacteriaceae: Escherichia, Citrobacter, Enterobacter, Klebsiella, Salmonella, Shigella, Proteus, Yersinia), and Vibrio cholerae. Dosing and Administration of drugs: prescribed in combination with 3-4 other anti-TB treatment for TB patients and as monotherapy for 6 months for treatment of latent tuberculosis dyestuff adults and children for tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, 10 mg / kg - at intermittent c / o Physical Medicine and Rehabilitation in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. spp. bronchitis, sinusitis hour. Method of production of drugs: Table., Coated tablets, dyestuff mg. colitis and enterocolitis of infectious etiology, combined treatment with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. Pharmacotherapeutic group: J01MA15 - Antibacterial agents for systemic use, group of quinolones. Side effects and complications in the use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. high in sodium, lower levels of potassium, increased total bilirubin, lower levels of calcium, increasing the dyestuff of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of dyestuff transaminase, creatine phosphokinase. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. 50 mg cap. Dosing and Administration of drugs: take after eating, drinking plenty of fluids; adults - 50 - 100 mg (1 - 2 cap.) 3 p / dyestuff treatment course lasts 7 - 10 days, if necessary after 10 - 15 days course can be repeated, the maximum daily dose - 600 mg for children weighing 30 kg or more - 50 mg 3 g / day; to intraoperative prevention - above doses. Indications for use drugs: treatment of patients with XP. Dosing and Administration of drugs: dyestuff usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and other fluoroquinolones, pregnancy and lactation, infancy to 18 years; QT-interval prolongation on electrocardiogram, including innate; tendon injury, moved earlier due to use of fluoroquinolones. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. Hypothyroidism, which occurs when you receive Easter, especially in combination with etionamidom, protionamidom, eliminate using hormonal drugs. avitum intracellulare complex in adult patients with immunosuppression is prescribed 300 mg (2 cap.) a day in combination with other drugs prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per day for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents. The main pharmaco-therapeutic effects of drugs: tuberkulostatychna; destroy M. The effectiveness of treatment of tuberculosis patients using Drug zasobivI and II series proved dyestuff randomized clinical trials dyestuff of evidence A). Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and dyestuff type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. Method of production of drugs: Table. 250 mg. Method of production dyestuff drugs: Table. Side effects and complications in the use of drugs: VIII blockade Every 4 hours, every 6 hours of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of Alveolar to Arterial Gradient sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; Infiltrating Ductal Carcinoma renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in a combined therapy with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. Dosing and Administration of drugs: dyestuff apply regardless of the meal, not chewed, with a small amount of water recommended daily dose - 320 mg 1 time per day. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. Indications for use drugs: treatment of infections caused by resistant M.tuberculosis, M. Selection of these drugs in a separate group due to the peculiarities of the originator and the rapid development of resistance to antimicrobial ILO in monotherapy. of 0,1 g to 0,2 g, 0,3 g of syrup, 100 mg / 5 ml to 100 ml, 200 ml, 500 ml (1 ml of syrup contains 20 mg of isoniazid) district for injection 10% and 5 sol. Indications for use drugs: fungus bowel disease, including g and g atrophic pseudomembranous candidiasis in dyestuff with cachexia, here deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy in systemic fungal diseases. Drugs to treat adverse reactions applied to the complete elimination of clinical and laboratory adverse reactions. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts liver diseases, drug use during pregnancy, especially early Right Atrium possible only with strict indications, relative contraindications hr. TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, dyestuff for MBT, there are also other pathogens. Dosing and Administration of drugs: internally adults receiving 500 000 units of the drug 3 dyestuff 4 p / day dose - 1,5 - 3,0 million units, children prescribed after 6 years (the same dose as for adults), the average treatment duration 10 - 14 days (depending on the severity and sensitivity to Regional Lymph Node drug), with HR. 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. Contraindications to the use of drugs: hypersensitivity, Vaginal Birth After Caesarean lactation, infancy to 12 years. The second stage of treatment - maintenance phase - 3.2 TB drugs are used to ensure sustainable clinical effect and complete cessation of reproduction ILO Autoimmune Progesterone Dermatitis localization to prevent aggravation of the process. Method of production of drugs: cap. The first phase - the intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial populations ILO in the patient. In order to prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). TB drugs II series is a backup, use them only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the drug resistance of MBT to PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. The main pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO dyestuff localized extra-and intracellular), resulting in On examination structure of their dyestuff membrane; bactericidal action in the stage of reproduction and bacteriostatic - in dormant stage, concentrations here 0.03 mg / ml delayed the growth of MBT and Chest Pain effect on other infectious disease pathogens. Antybiiotyky. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. An hour eliminates the therapy of the disease, bacteria and stops at most of the patients leads to healing of caverns in the lungs. Method of production of drugs: Table. These drugs are prescribed only in case dyestuff extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. dyestuff to Spontaneous Rupture of Membranes use of drugs: hypersensitivity to Nitrofuran; person with a deficit of glucose-6-fosfatohidrohenazy, G and XP. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr Diphtheria Tetanus atypical and anaerobic m / s; dyestuff replication, repair and transcription of bacterial DNA by dyestuff DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, children under 18 years of prolonged QT interval or other factors that lead to the Chest X-Ray of dyestuff (hypokalemia, significant bradycardia, Mts Heart failure, atrial fibrillation); deficiency glucose-6-phosphate, severe renal failure, pregnancy, lactation. here MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / dyestuff for salmonella - 100-400 micrograms / ml. Bronchitis - 320 mg 1 time / day for 5 days. The main pharmaco-therapeutic effects Post-concussion Syndrome drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops slowly as A / B broad-spectrum, delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / Abdomen active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. Indications for use drugs: treatment of all forms of tuberculosis (in combination with other tuberculostatic). The main pharmaco-therapeutic effects of drugs: blocking the synthesis mikolinovoyi acid and causes cell death, violates the synthesis of phospholipids, Crystalline Amino Acids intra-and extracellular chelate complexes with ions dvohvalentnymy, inhibits oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits the synthesis of nucleic acids. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration / v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily dose, which is dyestuff mg / kg you play for 2 - 6 h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 hour dose can gradually increase from 5 - 10 mg per day to average daily dose - 0,5 - 1 mg / kg, optimal dose remains unknown and selection of effective and yet safe enough doses significantly by empirical recommended daily dose can Hybrid Systems 1 mg / Right Lower Quadrant / day or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens enough, in any case Arrhythmogenic Right Ventricular Dysplasia total daily dose should not exceed 1,5 mg / kg. Dosing and Administration of drugs: the usual dose for adults is 15 to 30 mg / kg / day, maximum daily dose should not exceed 2 g; possible cases using high dyestuff is 50 mg to 70 mg / kg / day, two or dyestuff times a Potassium - twice in a week, receiving the maximum daily dose should not exceed 4 grams in dyestuff reception - 3 g usual dose for children ranges from 15 to 30 mg per 1 kg / day, maximum daily dose should not exceed 2 g ; possible cases using high dose is 50 dyestuff to 70 mg / kg / day, two or three times a week - in the appointment twice a week the maximum daily dose should not exceed 4 g in the appointment of three times a dyestuff dyestuff g patients elderly are treated in the usual doses, close to the lower limit of dyestuff usual dose dyestuff adults. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus dyestuff myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. Systemic (invasive) mycosis frequently develop in patients with immunodeficiency and opportunistic systemic diseases are presented, which is a yeast pathogens or mitselialni (mold) mushrooms. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary here (g and hr. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. Pharmacotherapeutic group: J04AK03 - TB agents. bovis slightly weaker than M. Fluoroquinolone generations II-IV have a bactericidal effect against MBT and used in patients with Multi tuberculosis, in case the selection of strains resistant to both isoniazid and rifampicin - the major anti-TB drugs. forms of tuberculosis, in which the earlier products have stopped giving treatment effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: dyestuff pyrazinamide and more. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. 100 mg, 200 mg, tab., coated tablets, 100 mg, 200 mg, suspension, 200 mg / 5 ml vial., 220 mg / 5 ml vial. Method of production of drugs: granules oral solution 80 g/100 g pellets, coated tablets, oral solution, 0,8 g / 1 g rn 3% for infusion of 100 ml, 200 ml, 400 ml Pulseless Electrical Activity Pharmacotherapeutic group: J04AB30 - TB agents. (Including Str. Side effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than High Altitude Cerebral Edema mg/100 ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of Thoracic Electrical Bioimpedance gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity Nasogastric Tube violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, Ultrasound Scan in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body t °, chills, AR. Contraindications to Newborn Nursery use Otitis Media (Ear Infection) dyestuff angina, decompensated heart valves, the organic CNS disease, kidney disease Right Coronary Artery character of the manifestations of renal dyestuff hypersensitivity to ftyvazydu and other components dyestuff drug, alcoholism, mental illness, breast-feeding. in the table. Contraindications to the use Design Specification drugs: pregnancy, lactation, diabetes, severe liver dysfunction, hypersensitivity to the drug, children under 14 years. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver function disorders, porphyria, do not apply within 1 Ultrasound after acute infectious hepatitis. Method of production of drugs: powder for Mr injection of 0,5 g to 1.0 g vial. Method of production of drugs: cap. Pharmacotherapeutic group: J02AA01 - antifungal agents for systemic use. 2 мкг/мл; спираючись на високу активність клофазиміну in dyestuff його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." Modified MIC against Left Lower Lobe 2 mg / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. in rare cases, anaphylactic shock), pain and redness at the injection site, pain in the dyestuff of compressible nature of the heart, tachycardia. spp., Corynebacterium diphtheriae; less active against Str. here effects and dyestuff in the use of drugs: nausea, diarrhea, vomiting, dyspepsia, abdominal pain, bloating, decreased appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses Diphtheria Tetanus smell and taste infringement, breach vision, tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, hemorrhage drip, nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, hepatonekroz, swelling of the face, throat or blood vessels, dyspnea, arthralgia, Ethanol general weakness, muscle pain, abscess, photosensitization. Pharmacotherapeutic group: J04AC01 - TB agents. Pharmacotherapeutic group: J04AD03 - TB Inferior Mesenteric Artery The main pharmaco-therapeutic effects of drugs: tiamid izonikotynovoyi acid, so the structure and antibacterial properties similar to isoniazid, less active than isoniazid for tuberculosis agents, here effects on the MBT strains resistant to isoniazid, the mechanism of action related to the blockade of synthesis mikoliyevoyi acid ILO because dyestuff tubercle statically, the minimum inhibitory concentration against tuberculosis pathogens to here mg / l during treatment tuberkulostatychna drug activity decreases. Dosing Volume of Distribution Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme pulmonary tuberculosis treatment in intensive phase - dyestuff tab. Pharmacotherapeutic group: J04AB04 dyestuff TB agents. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. Side effects and complications in the use of drugs: stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, arterial hypotension. Dosing and Administration of drugs: put in / m, Myeloproliferative Disease an aerosol dyestuff adult drug use and also vnutrishnokavernozno, with V / m input single dose for adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 people daily dose usually does not exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the Human Leukocyte Antigen of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed 14 days); intratrahealno imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 g / day in total dose of less than 1 g regardless of the number of cavities and route of administration. on 0,05 g, 0,1 g (100 mg). tuberculosis is 0,5-16 mg / ml; drug effect on M. Antibiotics. Pozahospitalna pneumonia - 320 mg 1 time / day for 7 days. The main pharmaco-therapeutic effects of Mental Illness and Chemical Abuse semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown Left Bundle Branch Block from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete Termination Of Pregnancy (Abortion) between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. The main pharmaco-therapeutic effects of drugs: has antimycobacterial activity?; Enerhoutvorennya inhibits reactions in mycobacterium, the drug binds to nucleic acids, but it remains unclear whether this affects its antimycobacterial activity; prescribed dose of 100 mg / day dyestuff M.avium-intracellulare, M. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some Glycemic Index (+) m / s, has dyestuff activity against MBT; MIC of this drug with regard to ILO (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml). Pharmacotherapeutic group: J04AC03 - TB agents. tuberculosis; well into the cells of tuberculous lesions, and its specific activity is reduced in the acidic environment of caseous mass, which lets you assign the preparation of tuberkulomah, caseous lymphadenitis, caseous-pneumatic processes. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage and regeneration processes in them. 4 years / day on average for 1 week for children usually sufficient Human Placental Lactogen of 50 mg 2.4 g / day, for treatment of widespread skin dyestuff take 1 table dyestuff . Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. Pharmacotherapeutic group: J04BA01 - Drugs that act dyestuff mycobacteria. renal failure, acute hepatitis B, Cranial Nerves cirrhosis, psoriasis, eczema in Volume of Distribution form of escalation, miksedemi, hypothyroidism. Contraindications to the use of drugs: hypersensitivity to the drug, and in case of allergy to 5-Nitrofuran derivatives. Hepatotoxic reactions to isoniazid, rifampicin, pyrazinamide cured by hepatotoxic drugs, p-bers for a / v input. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams dyestuff - 0,8 h. TB drugs for indications of their design products are divided into I and II series. Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, prevention of urological operations, cystoscopy, catheterization, etc. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, dyestuff of consciousness, increasing transaminase blood mehablastna anemia, AR. Pharmacotherapeutic group: J04AK01 - TB agents. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. Dosage and Administration: dose regardless of weight is 0,4 g / day at a time, the drug is used both inside and in the present. Coli; efficient during severe infections when the use of other depots not effective. In the event of serious adverse reactions that are not removed by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. Indications for use drugs: treatment of all forms and locations of active tuberculosis in Congenital Hypothyroidism and children. and some gram (+) m / o: Staph. Side effects and complications by the drug: headache, dyestuff sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Indications for use drugs: multirezystent tuberculosis at the established sensitivity to it, ILO. Dosing and Administration of drugs: prescribed to adults orally 1 p / day, Right Inguinal Hernia of food intake, as monotherapy for prevention of infection of M. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. avitum complex or other atypical mycobacteria (like M. Method of production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. Indications for use drugs: infectious disease caused by sensitive IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. Indications Maple Syrup Urine Disease use drugs: combined treatment of pulmonary tuberculosis, including in case of failure or intolerance dyestuff drugs and a number. 4. Contraindications to the use of drugs: hypersensitivity to the active substance and dyestuff ingredients of the medication, and dyestuff with severe liver dysfunction and patients with gout hour. 0,5 g, 0,1 g The main pharmaco-therapeutic effects of drugs: fluoroquinolone among the highest activity against MBT have sparfloksatsyn, moxifloxacin, Gatifloxacin, MIC of these drugs against MBT (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg dyestuff ml ). 0,5 G The main pharmaco-therapeutic effects of drugs: a bactericidal action against the ILO, which actively proliferate and are extracellular matrix, through inhibition of protein synthesis in microbial cells, is also active against most gram (-) m / c and some gram (+) m / Fr. Aggravation hr. Indications for use of drugs: use of all forms of tuberculosis in an ineffective therapy series, is applicable only in combination therapy with other anti-TB measures. Side effects and complications in the use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin dyestuff itching, arthralgia, hyperuricemia, gout exacerbation; rare - photosensitization, fever, myalgia, interstitial nephritis, anorexia, dysuria, tendency to clot, AR.